<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31153" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Vibrio cholerae Infection</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ojeda Rodriguez</surname>
            <given-names>Jafet A.</given-names>
          </name>
          <aff>USAF</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hashmi</surname>
            <given-names>Muhammad F.</given-names>
          </name>
          <aff>National Health Service</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kahwaji</surname>
            <given-names>Chadi I.</given-names>
          </name>
          <aff>Universtity of California, Irvine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jafet Ojeda Rodriguez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Hashmi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chadi Kahwaji declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>5</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31153.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Cholera is an acute&#x000a0;secretory diarrhea caused by toxigenic strains of<italic toggle="yes">&#x000a0;Vibrio cholerae</italic>,<italic toggle="yes">&#x000a0;</italic>a gram-negative, comma-shaped bacterium. Cholera<italic toggle="yes">&#x000a0;</italic>is characterized&#x000a0;by severe, acute, large-volume, watery diarrhea resulting in rapid dehydration and&#x000a0;is associated with high mortality if not treated promptly. Transmission occurs via&#x000a0;the fecal-oral route&#x000a0;through&#x000a0;contaminated water or food. Cholera, which is typically found in low- and middle-income countries, has historically been endemic in the Asian subcontinent, causing pandemics. Today, cholera persists in regions of the world with unsatisfactory hygienic conditions and regions afflicted by natural disasters and humanitarian crises. Water, sanitation, and hygiene are integral parts of preventing transmission. Prompt oral rehydration therapy and antibiotics are the cornerstones for the treatment of cholera. The new oral vaccines have increased survival and excellent prognosis with appropriate treatment. This activity outlines the epidemiology, evaluation, treatment, and prevention of cholera and underscores the role of the interprofessional team in the prompt evaluation and treatment of patients with this disease to improve their care and clinical outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the epidemiology of <italic toggle="yes">Vibrio cholerae</italic> infection.</p></list-item><list-item><p>Identify the clinical manifestations and risk factors associated with <italic toggle="yes">Vibrio cholerae</italic> infection.</p></list-item><list-item><p>Select the appropriate treatment and overall care plan&#x000a0;for patients infected with <italic toggle="yes">Vibrio cholerae.</italic></p></list-item><list-item><p>Collaborate with interprofessional healthcare teams to coordinate care and optimize outcomes for patients with <italic toggle="yes">Vibrio cholerae</italic> infection.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31153&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31153">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31153.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Toxigenic strains of <italic toggle="yes">Vibrio cholerae</italic> are a major cause of acute, severe, dehydrating diarrhea in low- and middle-income countries with unsatisfactory hygienic conditions and those affected by natural disasters and humanitarian crises. <xref ref-type="bibr" rid="article-31153.r1">[1]</xref>&#x000a0;<italic toggle="yes">V cholerae </italic>is&#x000a0;a gram-negative, comma-shaped bacterium that causes&#x000a0;acute, large-volume, watery diarrhea that can result in rapid dehydration and hypovolemia. Cholera is a rapidly progressing illness and is associated with high mortality rates if not treated promptly. The case fatality ratio can exceed 50%&#x000a0;without appropriate treatment&#x000a0;but&#x000a0;decreases to less than 1% when prompt rehydration and antibiotics are administered.&#x000a0;<xref ref-type="bibr" rid="article-31153.r1">[1]</xref><xref ref-type="bibr" rid="article-31153.r2">[2]</xref>&#x000a0;<italic toggle="yes">V cholerae</italic> is transmitted through the fecal-oral route by contaminated water or food. Risk factors for acquiring&#x000a0;<italic toggle="yes">V cholera</italic> include poverty, inadequate sanitation, contaminated water, and food.<xref ref-type="bibr" rid="article-31153.r1">[1]</xref><xref ref-type="bibr" rid="article-31153.r3">[3]</xref>&#x000a0;</p>
        <p>Cases of cholera are commonly underreported for many reasons, including a lack of appropriate surveillance and resources. The World Health Organization (WHO) estimates that annually there are 1.4 to 4.0 million cases and 21,000 to 143,000 deaths worldwide from cholera.<xref ref-type="bibr" rid="article-31153.r4">[4]</xref>&#x000a0;Historically, cholera has been endemic&#x000a0;in the Asian subcontinent, but it has also established itself in other regions and is now endemic in Latin and Central America and sub-Saharan Africa.<xref ref-type="bibr" rid="article-31153.r4">[4]</xref></p>
        <p>Over&#x000a0;the past&#x000a0;2 centuries,<italic toggle="yes"> V cholerae</italic> has caused&#x000a0;7 pandemics. The seventh pandemic, which is still ongoing, was first reported in 1961 in Sulawesi, an island governed by Indonesia, in 1971 in Africa, and in 1991 in the Americas.<xref ref-type="bibr" rid="article-31153.r5">[5]</xref>
<italic toggle="yes">V cholerae</italic> is constantly evolving, with new genotypes and phenotypes emerging, most likely due to&#x000a0;antibiotic pressure.</p>
        <p>Cholera continues to be a significant public health threat for many reasons: its endemicity is expanding, outbreaks are unpredictable,&#x000a0;it has&#x000a0;high morbidity and mortality, it is underdetected and underreported, antimicrobial resistance is increasing, and resources for treatment are inadequate. The WHO's Global Task Force for Cholera Control (GTFCC), a global network of partners coordinated by the WHO, established an initiative with a goal to reduce cholera globally by 90% and eradicate the disease in at least 20 countries by 2030.<xref ref-type="bibr" rid="article-31153.r6">[6]</xref></p>
        <p>Appropriate oral and intravenous rehydration therapy and administering antibiotics and electrolytes are the cornerstones for treating cholera. Oral cholera vaccines are a significant component of the treatment and control strategies implemented in endemic zones or during an outbreak. These vaccines have been shown to be effective in preventing and managing cholera. Water, sanitation, and hygiene (WASH) practices are also crucial in preventing the transmission of <italic toggle="yes">V cholera</italic>.<xref ref-type="bibr" rid="article-31153.r1">[1]</xref></p>
      </sec>
      <sec id="article-31153.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">V cholerae </italic>is&#x000a0;a gram-negative, comma-shaped bacterium&#x000a0;responsible for causing is the cause of&#x000a0;cholera (see <bold>Image.</bold> Vibrio cholerae).&#x000a0;<italic toggle="yes">V cholerae</italic>&#x000a0;species are highly motile bacteria&#x000a0;with a single polar flagellum.&#x000a0;Transmission of <italic toggle="yes">V cholera</italic> occurs via the fecal-oral route&#x000a0;through contaminated water and food, fomites, and direct contact with infected individuals. This transmission mode is more pronounced in vulnerable communities affected by natural disasters, war, and famines.&#x000a0;<xref ref-type="bibr" rid="article-31153.r1">[1]</xref><xref ref-type="bibr" rid="article-31153.r3">[3]</xref>&#x000a0;Inter-household transmission has been documented, which can give rise to clustering patterns of cases.&#x000a0;<xref ref-type="bibr" rid="article-31153.r4">[4]</xref></p>
        <p><italic toggle="yes">V cholerae</italic> are free-living organisms and diverse species, encompassing pathogenic and non-pathogenic strains classified serologically based on the O antigen of their lipopolysaccharide.<xref ref-type="bibr" rid="article-31153.r1">[1]</xref>&#x000a0;<italic toggle="yes">V cholerae</italic>&#x000a0;is salt-tolerant,&#x000a0;requiring NaCl to grow, and can be found&#x000a0;naturally in aquatic coastal habitats and brackish water&#x000a0;contaminated with human or animal waste. This condition can explain the occasional infections&#x000a0;through shellfish.<xref ref-type="bibr" rid="article-31153.r7">[7]</xref>&#x000a0;Freshly shed feces&#x000a0;are hyperinfectious for 24 hours after being&#x000a0;released into the environment but can survive for a long time outside the gut.&#x000a0;<xref ref-type="bibr" rid="article-31153.r8">[8]</xref> More than 200 serogroups of <italic toggle="yes">V cholerae</italic> have been identified, but only the toxigenic strains of <italic toggle="yes">V cholera</italic> cause cholera, and of those, only serogroups O1 and O139&#x000a0;cause cholera epidemics.&#x000a0;<xref ref-type="bibr" rid="article-31153.r1">[1]</xref>&#x000a0;Non&#x02013;toxin-producing strains of&#x000a0;<italic toggle="yes">V cholerae</italic>&#x000a0;non-O1 and non-O139 have been&#x000a0;reported as the cause of smaller outbreaks&#x000a0;and isolated cases of diarrhea, and <italic toggle="yes">V</italic>&#x000a0;<italic toggle="yes">cholerae</italic> non&#x02013;toxin-producing non-O1 and non-O139 strains have been&#x000a0;reported as the cause of&#x000a0;sporadic gastroenteritis and sepsis.<xref ref-type="bibr" rid="article-31153.r9">[9]</xref>&#x000a0;</p>
        <p>Serogroup O1 contains serotypes Inaba and Ogawa and 2&#x000a0;biotypes, classical and El Tor, which cause&#x000a0;cholera epidemics. The first 6 pandemics were likely caused by the classical biotype belonging to serotype O1, and the ongoing seventh pandemic (7P) that started in 1961 is caused by the O1 El Tor biotype&#x000a0;(7&#x02009;PET).&#x000a0;In 1992, the&#x000a0;<italic toggle="yes">V cholera</italic> serotype O139, known as Bengal, emerged in the Indian subcontinent as another epidemic variant&#x000a0;of&#x000a0;<italic toggle="yes">V cholerae</italic>, after that,<italic toggle="yes">&#x000a0;</italic>spreading to other areas in Asia and causing large epidemics.<xref ref-type="bibr" rid="article-31153.r10">[10]</xref><xref ref-type="bibr" rid="article-31153.r7">[7]</xref></p>
        <p>Phylogenetic analyses using whole-genome analyses have tracked the worldwide circulation of 7PET lineages, establishing that a single lineage, 7PET, is responsible for the current pandemic and identifying the Bay of Bengal as the original source of <italic toggle="yes">V cholerae.</italic><xref ref-type="bibr" rid="article-31153.r4">[4]</xref><xref ref-type="bibr" rid="article-31153.r11">[11]</xref>&#x000a0;Spread occurs with human travel, causing local and long-lived regional outbreaks.&#x000a0;</p>
        <p>The&#x000a0;<italic toggle="yes">V cholerae</italic>&#x000a0;genome&#x000a0;contains two chromosomes distinct from other bacteria.&#x000a0;<italic toggle="yes">V cholerae</italic>&#x000a0;evolves&#x000a0;quickly by&#x000a0;acquiring&#x000a0;mobile genetic elements. Examples of unique features of the&#x000a0;<italic toggle="yes">V. cholerae</italic>&#x000a0;genome&#x000a0;include the bacteriophage CTX&#x003a6;, which is a lysogenic bacteriophage&#x000a0;that infects bacteria and inserts genetic material into the genome, and the&#x000a0;<italic toggle="yes">Vibrio</italic>&#x000a0;pathogenicity island, which&#x000a0;encodes the toxin that allows intestinal colonization.<xref ref-type="bibr" rid="article-31153.r12">[12]</xref></p>
      </sec>
      <sec id="article-31153.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The actual global burden of cholera is not known because cases are underdiagnosed and underreported worldwide. Limited resources for the diagnosis and surveillance of cholera and poor access to healthcare in many areas of the world lead to many cases being undetected.&#x000a0;The WHO estimates that annually there are 1.4 to 4.0 million cases and 21,000 to 143,000 deaths worldwide from cholera.<xref ref-type="bibr" rid="article-31153.r4">[4]</xref>&#x000a0;Cholera has historically been endemic&#x000a0;in the Asian subcontinent but has also established itself in other regions and is now endemic in Latin and Central America and sub-Saharan Africa. Over the past&#x000a0;two centuries,<italic toggle="yes">&#x000a0;V cholerae</italic>&#x000a0;has caused&#x000a0;7 pandemics. The seventh pandemic, which is still ongoing, was first&#x000a0;reported in 1961 in Sulawesi, an island governed by Indonesia,&#x000a0;in 1971 in Africa, and in 1991 in the Americas.<xref ref-type="bibr" rid="article-31153.r5">[5]</xref>&#x000a0;<italic toggle="yes">V cholerae</italic>&#x000a0;is constantly evolving, and new genotypes and phenotypes are being produced due to the pressure of antibiotic use.</p>
        <p>Serogroup O1 contains serotypes Inaba and Ogawa and 2&#x000a0;biotypes, classical and El Tor, which cause&#x000a0;cholera epidemics. The first 6 pandemics were likely caused by the classical biotype belonging to serotype O1, and the ongoing seventh pandemic (7P) that started in 1961 is caused by the O1 El Tor biotype&#x000a0;(7&#x02009;PET).&#x000a0;In 1992, the&#x000a0;<italic toggle="yes">V cholera</italic>&#x000a0;serotype O139, known as Bengal, emerged in the Indian subcontinent as another epidemic variant&#x000a0;of&#x000a0;<italic toggle="yes">V cholerae,&#x000a0;</italic>thereafter<italic toggle="yes">&#x000a0;</italic>spreading to other areas in Asia and causing large epidemics.<xref ref-type="bibr" rid="article-31153.r10">[10]</xref><xref ref-type="bibr" rid="article-31153.r7">[7]</xref>&#x000a0;</p>
        <p>Phylogenetic analyses using whole-genome sequencing have facilitated our better understanding of the evolution of <italic toggle="yes">V cholerae</italic> and have tracked the worldwide circulation of 7PET lineages. We now know that a single lineage, 7PET, is responsible for the current pandemic by the expansion of a single bacterial lineage associated with 3 waves of transmission that allowed the acquisition of new genetic material.<xref ref-type="bibr" rid="article-31153.r4">[4]</xref><xref ref-type="bibr" rid="article-31153.r11">[11]</xref>&#x000a0;This evolutionary process allowed&#x000a0;the bacterium to have improved environmental compatibility, increased antimicrobial resistance, and increased virulence compared to previous strains of <italic toggle="yes">V cholerae</italic>. These analyses pointed to the Bay of Bengal as the original source of&#x000a0;<italic toggle="yes">V cholerae</italic>,&#x000a0;causing&#x000a0;6 pandemics from 1827 through 1923. The seventh pandemic has been ongoing since 1961, reaching&#x000a0;South America&#x000a0;and most of the Western Hemisphere in 1991.<xref ref-type="bibr" rid="article-31153.r13">[13]</xref>.&#x000a0;Recently, cholera has continued to affect vulnerable communities&#x000a0;such as post-earthquake Haiti (2010),&#x000a0;Iraq, and&#x000a0;Yemen, where natural disasters, refugee movements, war, and conflict increase the risk of infection and outbreaks.<xref ref-type="bibr" rid="article-31153.r10">[10]</xref><xref ref-type="bibr" rid="article-31153.r14">[14]</xref>&#x000a0;Although safe drinking water and advanced sanitation systems have made cholera a treatable illness in Europe and North America, new&#x000a0;<italic toggle="yes">V cholerae&#x000a0;</italic>strains, ease of travel, and constant migration of possibly infected individuals have raised serious public health concerns.<xref ref-type="bibr" rid="article-31153.r15">[15]</xref></p>
      </sec>
      <sec id="article-31153.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p><italic toggle="yes">V cholerae</italic>&#x000a0;is a gram-negative aerobic or facultative anaerobic comma-shaped bacillus.<bold>&#x000a0;</bold>The antigenic structure of the bacterium comprises a somatic O antigen and a flagellar H antigen. The latter distinguishes pathogenic from nonpathogenic strains.&#x000a0;To reach the small intestine, the organism has to&#x000a0;pass&#x000a0;through the stomach and survive the low gastric pH. <italic toggle="yes">V cholerae</italic> is not acid-resistant; therefore, it requires a large inoculum size to&#x000a0;survive the gastric acid in the stomach (10^8).<xref ref-type="bibr" rid="article-31153.r4">[4]</xref><xref ref-type="bibr" rid="article-31153.r16">[16]</xref>&#x000a0;Once it passes through the stomach, it enters the small intestine colonization. <italic toggle="yes">V cholerae </italic>then&#x000a0;moves to the epithelial cells, where it adheres, multiplies, and secretes cholera toxin, which is eventually endocytosed by the intestinal epithelial cells. This cholera toxin has an A1 subunit, which activates&#x000a0;adenylate cyclase&#x000a0;to increase cyclic adenosine monophosphate (cAMP). cAMP inhibits the absorption of sodium and chloride from the microvilli and increases the secretion of chloride and water from the crypt cells, causing profuse, isotonic, watery diarrhea.<xref ref-type="bibr" rid="article-31153.r4">[4]</xref>&#x000a0;When&#x000a0;the toxin enters the epithelial cells, it alters the electrolyte channels, resulting in endoluminal fluid loss rich in chloride, bicarbonate, sodium, and potassium.<xref ref-type="bibr" rid="article-31153.r17">[17]</xref>&#x000a0;Once the&#x000a0;<italic toggle="yes">V cholerae</italic>&#x000a0;is excreted into the environment, it remains hyperinfectious for the next 24 hours, which may contribute to the explosive nature of cholera epidemics.<xref ref-type="bibr" rid="article-31153.r18">[18]</xref></p>
        <p>In addition to the inoculum size, other factors also influence an individual's susceptibility to&#x000a0;<italic toggle="yes">V cholerae </italic>infection and&#x000a0;the severity of illness.&#x000a0;Individuals with blood group O are more likely to develop severe cholera compared to those with other blood&#x000a0;types, and prior infection or vaccination against cholera has often&#x000a0;been found to gain temporary acquired immunity.<xref ref-type="bibr" rid="article-31153.r19">[19]</xref><xref ref-type="bibr" rid="article-31153.r20">[20]</xref><xref ref-type="bibr" rid="article-31153.r21">[21]</xref>&#x000a0;Recently, there has been an increase in non-O1 and non-O139&#x000a0;<italic toggle="yes">V cholerae</italic>&#x000a0;infections presenting as self-limited gastroenteritis after bathing in contaminated recreational waters&#x000a0;or ingesting raw and undercooked seafood.<xref ref-type="bibr" rid="article-31153.r9">[9]</xref><xref ref-type="bibr" rid="article-31153.r22">[22]</xref></p>
        <p>The O139 Bengal strain of&#x000a0;<italic toggle="yes">V cholerae</italic>&#x000a0;acts similarly, except that it&#x000a0;has a novel O139 lipopolysaccharide and an immunologically linked O-antigen capsule.<xref ref-type="bibr" rid="article-31153.r23">[23]</xref> These two features increase its virulence, resistance to human serum, and the occasional development of O139 bacteremia.<xref ref-type="bibr" rid="article-31153.r23">[23]</xref></p>
      </sec>
      <sec id="article-31153.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p><italic toggle="yes">V cholerae</italic>&#x000a0;is a noninvasive&#x000a0;bacterium&#x000a0;that causes&#x000a0;secretory diarrhea by colonizing the small intestine and producing cholera toxin. Transmission of&#x000a0;<italic toggle="yes">V cholera</italic>&#x000a0;occurs&#x000a0;via the fecal-oral route&#x000a0;through contaminated water and food, fomites, and direct contact with infected infected individuals.<bold>&#x000a0;</bold><italic toggle="yes">V cholera</italic> attaches to the small intestine and produces cholera toxins. These bacteria have specialized adherence factors that allow them to adhere to the hostile microvilli surface. Once attached,&#x000a0;<italic toggle="yes">V cholera&#x000a0;</italic>exports 1 of 2 antigenically related but distinct forms of cholera enterotoxin (CT-1 or CT-2) into the intestinal epithelial cell. The cholera toxin causes adenylate cyclase to be locked on the on mode, leading to an excess in cAMP and subsequent hypersecretion of chloride and bicarbonate followed by water.<xref ref-type="bibr" rid="article-31153.r7">[7]</xref></p>
      </sec>
      <sec id="article-31153.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Cholera is typically characterized by&#x000a0;profuse, painless diarrhea and vomiting without a fever, although the diarrhea may be of varied severity. Severe cases may present with hypovolemic shock due to significant fluid and electrolyte loss. Although initial diarrhea may include fecal material, the classic diarrhea presentation consists of&#x000a0;watery, foul-smelling mucous described as rice-water stools. The rate of fluid loss and&#x000a0;high stool sodium&#x000a0;concentration distinguish cholera&#x000a0;from other&#x000a0;diarrheal diseases.<xref ref-type="bibr" rid="article-31153.r24">[24]</xref></p>
        <p>In severe cases, known as cholera gravis, hypotensive shock can develop within hours of the initial symptoms. If treatment is not started immediately, death may occur. Mortality rates&#x000a0;are reported to be as high as 70%.<xref ref-type="bibr" rid="article-31153.r25">[25]</xref>&#x000a0;Cholera sicca is a variant of the disease when fluid accumulates in the intestinal lumen, followed by circulatory collapse and death before any diarrheal symptoms arise.<xref ref-type="bibr" rid="article-31153.r26">[26]</xref></p>
        <p>Clinical findings in patients with&#x000a0;hypovolemic shock may include decreased urine output, cold, clammy skin, decreased skin turgor, sunken eyes, Kussmaul breathing (acidosis), tachycardia, and&#x000a0;hypotension. Electrolyte imbalances can cause muscle cramping and weakness.<xref ref-type="bibr" rid="article-31153.r27">[27]</xref>&#x000a0;</p>
        <p>Clinical signs of cholera depend on the level of volume contraction. Symptoms and signs associated with the percentages of fluid lost are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>3% to 5% loss of body weight - excessive thirst</p>
          </list-item>
          <list-item>
            <p>5% to 8% loss of body weight - postural hypotension, weakness, tachycardia, fatigue, dry mucous membranes, or dry mouth</p>
          </list-item>
          <list-item>
            <p>&#x0003e;10% loss of body weight - oliguria; weak, thready, or absent pulse; sunken eyes (sunken fontanelles in infants); wrinkled washerwoman skin; and hypersomnolence and coma</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31153.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p><italic toggle="yes">V cholera</italic> is mainly diagnosed clinically in the setting of a diarrheal illness outbreak. Various factors differentiate it from other diarrheal diseases. Given the pathophysiology of cholera and its effects on chloride secretion through apical channels and inhibition of sodium chloride absorption,&#x000a0;laboratory results&#x000a0;often reveal hypokalemia, hypocalcemia, metabolic acidosis, and isonatremic dehydration.<xref ref-type="bibr" rid="article-31153.r27">[27]</xref><xref ref-type="bibr" rid="article-31153.r28">[28]</xref>&#x000a0;In children, severe hypoglycemia may occur, coupled with altered mental status, seizures, and coma.<xref ref-type="bibr" rid="article-31153.r29">[29]</xref>&#x000a0;Otherwise, no strict laboratory or radiographic findings are required to diagnose and care for cholera patients.</p>
        <p>Confirmatory <italic toggle="yes">V cholerae</italic> diagnosis involves isolating&#x000a0;the&#x000a0;bacteria in stool cultures by polymerase chain reaction and rapid tests. Nonetheless, given the&#x000a0;morbidity and mortality associated with the disease, treatment is never to be delayed for diagnostic testing, as clinical diagnosis is usually sufficient.<xref ref-type="bibr" rid="article-31153.r25">[25]</xref>&#x000a0;Stool culture remains the gold standard for detecting&#x000a0;<italic toggle="yes">V cholerae</italic>,<italic toggle="yes">&#x000a0;</italic>and susceptibilities are performed using selective&#x000a0;media. Stool culture requires time, however, and&#x000a0;is&#x000a0;not the appropriate technique when a&#x000a0;rapid diagnosis is necessary.<xref ref-type="bibr" rid="article-31153.r30">[30]</xref></p>
        <p>Rapid diagnostic tests have commanded greater attention&#x000a0;compared to stool culture due to their ease of&#x000a0;use in field settings, low cost, and rapid turnaround time, which can be important in setting up and performing epidemic and preventive surveillance.<xref ref-type="bibr" rid="article-31153.r31">[31]</xref><xref ref-type="bibr" rid="article-31153.r32">[32]</xref>&#x000a0;Most&#x000a0;rapid diagnostic tests follow the principles of dipstick tests by applying a fresh stool sample&#x000a0;to the stick and adding specific reagents to produce a positive or negative result.<xref ref-type="bibr" rid="article-31153.r2">[2]</xref>&#x000a0;Given the importance of the WHO on faster, easier, and less expensive diagnostic tests, new rapid diagnostic tests are developed periodically. Recently, enriched rapid diagnostic tests have shown diagnostic performance equivalent to cultures.<xref ref-type="bibr" rid="article-31153.r33">[33]</xref><xref ref-type="bibr" rid="article-31153.r34">[34]</xref><xref ref-type="bibr" rid="article-31153.r35">[35]</xref>&#x000a0;On the downside, recent outbreaks, similar to the one that occurred in Haiti after the&#x000a0;2010 earthquake, have revealed the drawbacks of relying too heavily on rapid diagnostic tests that have significant variations. While these tests are useful for outbreak response and surveillance, they are not optimal for use as point-of-care tests.<xref ref-type="bibr" rid="article-31153.r36">[36]</xref></p>
      </sec>
      <sec id="article-31153.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Oral rehydration therapy is the mainstay treatment&#x000a0;for acute cholera infection and has&#x000a0;dramatically improved patient outcomes globally when&#x000a0;given to patients&#x000a0;for cholera&#x000a0;and&#x000a0;all other dehydrating diarrheal diseases.<xref ref-type="bibr" rid="article-31153.r37">[37]</xref>&#x000a0;The level of hypovolemia determines the fluid replacement requirement,&#x000a0;correlating it&#x000a0;to findings on&#x000a0;the physical examination such as ear, nose, throat, skin pinch, pulse, and mental status.&#x000a0;There are three levels:&#x000a0;none, some, or severe volume depletion.<xref ref-type="bibr" rid="article-31153.r38">[38]</xref>&#x000a0;Given the average loss&#x000a0;of 20 mL/kg/h&#x000a0;in patients affected by cholera,&#x000a0;rehydration must&#x000a0;be started&#x000a0;immediately.&#x000a0;After assessing the initial&#x000a0;volume deficit, the route of rehydration is determined and started as soon as possible. Patients with severe dehydration are typically in hypovolemic shock. They require emergent&#x000a0;intravenous rehydration of as much as 350 mL/kg in the first 24 hours, with complete fluid deficit replaced during the first 3 to 4 hours.<xref ref-type="bibr" rid="article-31153.r39">[39]</xref>&#x000a0;Oral rehydration then begins as soon as the patient can drink.</p>
        <p>Oral rehydration therapy was originally developed in the 1960s as an equimolar oral rehydration solution rich in sodium and glucose to respond to the small intestine's severe electrolyte and fluid losses.<xref ref-type="bibr" rid="article-31153.r40">[40]</xref>&#x000a0;Today, different oral rehydration solutions (ORS) are recommended for treating cholera. Since 2002, the WHO has recommended a reduced osmolar ORS that reduces&#x000a0;stool fluid and electrolyte depletion.<xref ref-type="bibr" rid="article-31153.r41">[41]</xref>&#x000a0;Other forms of ORS, such as rice-derived,&#x000a0;non-absorbed starch,&#x000a0;polymer-based,&#x000a0;and homemade ORS, have also shown a reduction in stool output and fluid and electrolyte losses.<xref ref-type="bibr" rid="article-31153.r42">[42]</xref><xref ref-type="bibr" rid="article-31153.r43">[43]</xref><xref ref-type="bibr" rid="article-31153.r44">[44]</xref><xref ref-type="bibr" rid="article-31153.r45">[45]</xref></p>
        <p>Other&#x000a0;types of&#x000a0;oral rehydration therapy reported involve the&#x000a0;initial administration of glucose solution without salts for a&#x000a0;more gradual correction of dehydration.<xref ref-type="bibr" rid="article-31153.r46">[46]</xref>&#x000a0;Nonetheless, all&#x000a0;solutions composed of salt, water, and glucose have been&#x000a0;shown to increase sodium reabsorption through the sodium-glucose-linked transporter in the intestinal wall&#x000a0;and&#x000a0;can be life-saving.<xref ref-type="bibr" rid="article-31153.r47">[47]</xref></p>
        <p>Patients experiencing severe vomiting in addition to diarrhea require special attention and additional measures. In these circumstances, ORS is typically not sufficient, and intravenous rehydration must be started to avoid the progression of dehydration. Continuous assessment for ongoing fluid loss is deemed paramount to ensure that fluid replacement is maintained and that volume status is periodically reassessed. For this purpose, cholera cots, where patients defecate directly into a measuring collection bucket, were developed.<xref ref-type="bibr" rid="article-31153.r15">[15]</xref></p>
        <p>The&#x000a0;most&#x000a0;common mistake when treating patients with cholera&#x000a0;is underestimating their correct fluid requirement and&#x000a0;not reassessing the patients' ongoing fluid losses.<xref ref-type="bibr" rid="article-31153.r48">[48]</xref></p>
        <p>Antimicrobials&#x000a0;are considered an adjunctive treatment for&#x000a0;<italic toggle="yes">V cholerae&#x000a0;</italic>and are typically administered once the initial volume deficit is corrected and vomiting has ceased.&#x000a0;Antimicrobials result in a substantial improvement in clinical and microbiological outcomes. They shorten the mean duration of diarrhea from 5 days to 1 to 2 days, reduce the total stool volume by 50%, reduce the amount of rehydration fluid required by 40%, and reduce the amount of excretion of hyperinfective bacteria by 3 days.<xref ref-type="bibr" rid="article-31153.r49">[49]</xref>&#x000a0;Although the initial empiric therapy is&#x000a0;typically based on the availability of antimicrobials and the antimicrobial resistance patterns locally, most strains are, in fact, susceptible to tetracyclines, and doxycycline is the drug of choice.&#x000a0;<xref ref-type="bibr" rid="article-31153.r4">[4]</xref>&#x000a0;Tetracyclines are the&#x000a0;most studied and used antimicrobials for cholera.<xref ref-type="bibr" rid="article-31153.r50">[50]</xref>&#x000a0;In comparison&#x000a0;studies, tetracyclines and azithromycin may have advantages over other&#x000a0;antimicrobials when comparing the duration of diarrhea.<xref ref-type="bibr" rid="article-31153.r49">[49]</xref>&#x000a0;Recently, reports of resistance to azithromycin have emerged, requiring caution when&#x000a0;administering without knowing the local antimicrobial susceptibility patterns.<xref ref-type="bibr" rid="article-31153.r4">[4]</xref>&#x000a0;The development of resistance to antimicrobials is a global concern because treatment options can be limited, and patient outcomes may be worse.<xref ref-type="bibr" rid="article-31153.r1">[1]</xref></p>
        <p>Infants diagnosed with cholera should be treated with ORS while breastfeeding, and zinc supplementation is also recommended.<xref ref-type="bibr" rid="article-31153.r51">[51]</xref>&#x000a0;In addition, vitamin&#x000a0;A&#x000a0;supplementation has been shown to reduce morbidity and mortality in children from 6 months to 5 years.<xref ref-type="bibr" rid="article-31153.r52">[52]</xref></p>
        <p>Antiemetics and antimotility agents have been found to have no benefit and may impede ORS therapy, hence producing worse outcomes.<xref ref-type="bibr" rid="article-31153.r25">[25]</xref><xref ref-type="bibr" rid="article-31153.r53">[53]</xref></p>
      </sec>
      <sec id="article-31153.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The clinical presentation of infection with <italic toggle="yes">V cholerae</italic> may be indistinguishable from infections with other pathogens. Patients with cholera can have varied degrees of acuity ranging from uncomplicated diarrhea to severe, watery, dehydrating diarrhea with vomiting that can cause hypovolemic shock within hours. Many infectious and noninfectious causes can manifest with acute watery diarrhea and can potentially mimic cholera.&#x000a0;As cholera needs to be promptly diagnosed and treated,&#x000a0;it should always be included in the differential diagnosis of diarrhea when a new patient is being evaluated. A high index of suspicion is required when patients have diarrhea in an outbreak setting or an endemic area. The differential diagnosis is broad, including infectious and noninfectious causes. Obtaining a thorough medical, exposure, and travel history is crucial to assess the patient's risk factors for cholera.<xref ref-type="bibr" rid="article-31153.r54">[54]</xref></p>
        <p>In resource-limited settings where cholera is common, giardia, rotavirus, and cryptosporidium are commonly identified as significant causative pathogens in infants and young children. In contrast, enterotoxigenic&#x000a0;<italic toggle="yes">Escherichia coli</italic>&#x000a0;is very common&#x000a0;in&#x000a0;older children and adults.</p>
        <p>The list below contains examples of causes of acute watery diarrhea that may have a similar clinical presentation to cholera and must be considered in patients' differential diagnoses. The list of diseases is&#x000a0;not meant to be exhaustive.<xref ref-type="bibr" rid="article-31153.r54">[54]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Other infectious causes of acute watery diarrhea can include enterotoxigenic <italic toggle="yes">E coli</italic>,&#x000a0;<italic toggle="yes">V cholerae</italic>&#x000a0;O1 or O139, <italic toggle="yes">Campylobacter</italic> spp, nontyphoidal&#x000a0;<italic toggle="yes">Salmonella enterica</italic>,<italic toggle="yes"> Aeromonas </italic>spp, enteroaggregative&#x000a0;<italic toggle="yes">E coli</italic>, norovirus, adenovirus, and rotavirus.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Other infectious causes&#x000a0;of acute bloody diarrhea can include&#x000a0;<italic toggle="yes">Shigella</italic> spp,&#x000a0;<italic toggle="yes">Campylobacter</italic>&#x000a0;spp, enteroinvasive&#x000a0;<italic toggle="yes">E coli</italic>, enterohemorrhagic&#x000a0;<italic toggle="yes">E coli</italic>, nontyphoidal&#x000a0;<italic toggle="yes">S enterica</italic>,<italic toggle="yes"> E histolytica</italic>, and&#x000a0;<italic toggle="yes"><italic toggle="yes">Schistosoma mansoni.</italic></italic></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31153.s11" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <p>In 2011, the WHO recognized the first oral cholera vaccine and started stockpiling&#x000a0;it in 2013.&#x000a0;Two additional oral cholera vaccines were added to the stockpile&#x000a0;in 2016. Although found to be a cost-effective short-to-medium term option compared to the high upfront costs of creating water, sanitation, and hygiene infrastructure from scratch, oral cholera vaccines have encountered numerous challenges that continue to be studied.<xref ref-type="bibr" rid="article-31153.r55">[55]</xref></p>
        <p>A 2017 study&#x000a0;discussing the 12 most recent oral cholera vaccine campaigns identified 3 main obstacles to more widespread vaccine use: regulatory hurdles (country-specific and time-consuming), cold-chain logistics (challenging to maintain in low-resource settings), and vaccine coverage/uptake.<xref ref-type="bibr" rid="article-31153.r56">[56]</xref> An effective and immediate approach for utilizing oral cholera vaccines from the global stockpile must be developed to overcome the hurdles associated with disease prevention.<xref ref-type="bibr" rid="article-31153.r57">[57]</xref><xref ref-type="bibr" rid="article-31153.r58">[58]</xref><xref ref-type="bibr" rid="article-31153.r59">[59]</xref></p>
        <p>Current and future research areas include whether supplementation with probiotics, thus restoring the gut microbiota, can clinically manage patients with cholera, reduce antimicrobial use, and improve outcomes.<xref ref-type="bibr" rid="article-31153.r60">[60]</xref>&#x000a0;</p>
        <p>The WHO's GTFCC is a global network of partners coordinated by the WHO. One&#x000a0;of the most important goals of GTFCC is the WHO-backed Global Roadmap to 2030, whose goals are to reduce cholera globally by 90% and eradicate it in at least 20 countries by 2030.<xref ref-type="bibr" rid="article-31153.r6">[6]</xref>&#x000a0;To achieve these goals, they suggest a 3-pronged approach: early detection of cholera cases and prompt response to curtail outbreaks; implementation of a targeted multisectoral strategy to prevent cholera recurrence; and development of a coordinated mechanism for advocacy, technical support, and partnership at local and global levels.[4]<xref ref-type="bibr" rid="article-31153.r6">[6]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-31153.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Before the introduction of effective oral rehydration therapy, mortality rates in severe cholera were more than 50%, with&#x000a0;even higher rates in pregnant women and children. The average case fatality rates for the&#x000a0;United States of America and&#x000a0;Europe&#x000a0;are estimated to be 1%, which is the WHO-recommended percentage. In Africa, a marked decline in&#x000a0;mortality has occurred since 1970. The&#x000a0;case fatality rate was 1.9% to 2.9% in 2021 and 1.8% in 2023, exceeding the target level of 1%&#x000a0;<xref ref-type="bibr" rid="article-31153.r61">[61]</xref>. Lower case fatality rates are&#x000a0;observed in South America, presumably due to the availability of appropriate treatment facilities and trained personnel.</p>
      </sec>
      <sec id="article-31153.s13" sec-type="Complications">
        <title>Complications</title>
        <p>The most common and life-threatening&#x000a0;complication of&#x000a0;<italic toggle="yes">V cholerae&#x000a0;</italic>is severe&#x000a0;and rapid dehydration within hours, leading to hypovolemic shock and metabolic acidosis,&#x000a0;which can&#x000a0;potentially be fatal.<xref ref-type="bibr" rid="article-31153.r10">[10]</xref> However, with appropriate and prompt treatment, patients typically recover fully without any long-term sequelae.</p>
      </sec>
      <sec id="article-31153.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Cholera is&#x000a0;an infectious disease caused by ingesting food or water contaminated by the bacteria&#x000a0;<italic toggle="yes">V cholerae</italic>. Patients living in endemic areas and travelers to these regions should be educated on the importance of hand hygiene. In addition, boiling water before it is consumed or used to rinse food is imperative. As stated above, some vaccines can also be used in endemic areas. Patients who live or have traveled to endemic countries should be encouraged to seek medical attention immediately if they develop signs of cholera infection.</p>
        <p>The key to reducing morbidity and mortality from cholera is patient education about transmission risks, improving environmental living conditions, good hygiene, and implementing all prevention techniques outlined in the WHO.&#x000a0;Furthermore, understanding and addressing&#x000a0;the social dynamics that lead to cholera risk may be more effective for better targeting efforts and the possibility of eliminating cholera.<xref ref-type="bibr" rid="article-31153.r62">[62]</xref><xref ref-type="bibr" rid="article-31153.r63">[63]</xref></p>
        <p>Cholera infection rates and outbreaks have been closely linked to the socioeconomic characteristics of the region.<xref ref-type="bibr" rid="article-31153.r64">[64]</xref>&#x000a0;Cholera&#x000a0;reveals how a country's socioeconomic status can propagate a preventable disease. This circumstance has led&#x000a0;to increased research and teamwork between public health, government, and medical authorities&#x000a0;to develop oral cholera vaccines and improve implementation practices and strategies.<xref ref-type="bibr" rid="article-31153.r57">[57]</xref><xref ref-type="bibr" rid="article-31153.r59">[59]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-31153.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to keep in mind regarding&#x000a0;<italic toggle="yes">V cholerae</italic> infection are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cholera is an acute secretory diarrheal illness caused by the toxin of the comma-shaped gram-negative&#x000a0;<italic toggle="yes">V cholerae&#x000a0;</italic>bacterium that is known worldwide for its pandemic potential.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Cholera affects resource-poor and developing countries lacking water, sanitation, and hygiene infrastructure. Historically, it has been responsible for 7 pandemics. Currently, it is endemic in&#x000a0;69 countries, with particular severity in Sub-Saharan&#x000a0;Africa and the Middle East.<xref ref-type="bibr" rid="article-31153.r65">[65]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Infection begins with the ingestion of food or water contaminated with&#x000a0;<italic toggle="yes">V cholerae. V cholerae subsequently</italic>&#x000a0;colonizes the small intestine and produces toxins that&#x000a0;induce changes in the electrolyte channels in the small intestine, causing massive fluid&#x000a0;and electrolyte loss, clinically manifesting as&#x000a0;watery diarrhea.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>The clinical presentation consists of painless, severe, dehydrating watery diarrhea, often&#x000a0;resembling rice water, which&#x000a0;can rapidly lead to hypovolemic shock in a few hours if not promptly treated.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>A high index of suspicion must be present when managing patients with acute, watery diarrhea, especially in endemic areas or during an outbreak. The diagnosis&#x000a0;is clinical, but confirmation using stool cultures&#x000a0;on&#x000a0;special selective media is recognized as the gold standard. As stool cultures are impractical for use in&#x000a0;the field, rapid diagnostic tests such as dipsticks have been favored for outbreak&#x000a0;surveillance and control.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>ORS&#x000a0;is the mainstay treatment for cholera and consists of aggressive volume repletion depending on the initial level&#x000a0;of volume depletion and ongoing fluid losses.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Patients with cholera must be&#x000a0;given&#x000a0;fluids by replacing the initial volume deficit in the first 4 to 6 hours and giving 350 mL/kg of fluid&#x000a0;in the first 24 hours. Close monitoring of ongoing fluid losses is essential to prevent mortality.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Isotonic oral fluids are preferred except in severe cases and in patients actively vomiting, where&#x000a0;intravenous hydration may be needed.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Other treatment modalities, such as antibiotics and nutritional supplements, have been proven to help with symptom duration and severity. Tetracyclines and macrolides are considered first- and second-line therapy, respectively.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Although&#x000a0;adequate water, sanitation, and hygiene infrastructure are the main preventive measures, oral cholera vaccines are effective,&#x000a0;comparably inexpensive, and safe for&#x000a0;outbreak control in high-risk endemic areas.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31153.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Improving healthcare outcomes for patients in resource-poor and developing countries infected with <italic toggle="yes">V cholerae</italic> is an issue at the forefront of public health. Concerted local, regional, and global efforts&#x000a0;must be established to prevent, evaluate, diagnose, and treat patients with cholera. The care of patients with&#x000a0;cholera necessitates a collaborative approach among healthcare professionals to ensure patient-centered care and improve overall outcomes.</p>
        <p>Cholera presents a significant public health challenge requiring the collaboration of an interprofessional healthcare team. This team typically includes an epidemiologist, infectious disease specialist, primary care provider, infection control nurse, social workers, dietitians, emergency department staff, advanced practitioners, nurses, pharmacists, and other health professionals. Each team member should possess the essential clinical skills and knowledge to diagnose and manage suspected and confirmed cholera cases. This includes expertise in recognizing the varied clinical presentations and understanding the nuances of diagnostic techniques.&#x000a0;These teams have been shown to improve early&#x000a0;diagnosis and prompt treatment with improvement in morbidity and mortality.<xref ref-type="bibr" rid="article-31153.r1">[1]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-31153.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31153&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31153">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/vibrio-cholerae-infection/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=31153">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31153/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31153">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-31153.s18">
        <fig id="article-31153.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Vibrio cholerae. This illustration depicts a photomicrograph of a Gram-stained specimen, revealing the presence of numerous flagellated, <italic toggle="yes">Vibrio cholerae</italic>, also known as Vibrio comma bacteria. This particular strain of V. cholerae causes Asiatic cholera. Note the characteristic &#x0201c;comma&#x0201d; shape of these organisms. CDC. Public Domain Image.&#x000a0;</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="5324_lores" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-31153.s19">
        <title>References</title>
        <ref id="article-31153.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chowdhury</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Islam</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>McMillan</surname>
                <given-names>NAJ</given-names>
              </name>
              <name>
                <surname>Qadri</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis, Management, and Future Control of Cholera.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2022</year>
            <month>Sep</month>
            <day>21</day>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>e0021121</fpage>
            <pub-id pub-id-type="pmid">35726607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dick</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Guillerm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moussy</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chaignat</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Review of two decades of cholera diagnostics--how far have we really come?</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2012</year>
            <volume>6</volume>
            <issue>10</issue>
            <fpage>e1845</fpage>
            <pub-id pub-id-type="pmid">23071851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schaetti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sundaram</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Merten</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Nyambedha</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>Lapika</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chaignat</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Hutubessy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Comparing sociocultural features of cholera in three endemic African settings.</article-title>
            <source>BMC Med</source>
            <year>2013</year>
            <month>Sep</month>
            <day>18</day>
            <volume>11</volume>
            <fpage>206</fpage>
            <pub-id pub-id-type="pmid">24047241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kanungo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Azman</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Ramamurthy</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Deen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dutta</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cholera.</article-title>
            <source>Lancet</source>
            <year>2022</year>
            <month>Apr</month>
            <day>09</day>
            <volume>399</volume>
            <issue>10333</issue>
            <fpage>1429</fpage>
            <page-range>1429-1440</page-range>
            <pub-id pub-id-type="pmid">35397865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaper</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Cholera.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-86</page-range>
            <pub-id pub-id-type="pmid">7704895</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Legros</surname>
                <given-names>D</given-names>
              </name>
              <collab>Partners of the Global Task Force on Cholera Control</collab>
            </person-group>
            <article-title>Global Cholera Epidemiology: Opportunities to Reduce the Burden of Cholera by 2030.</article-title>
            <source>J Infect Dis</source>
            <year>2018</year>
            <month>Oct</month>
            <day>15</day>
            <volume>218</volume>
            <issue>suppl_3</issue>
            <fpage>S137</fpage>
            <page-range>S137-S140</page-range>
            <pub-id pub-id-type="pmid">30184102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r7">
          <label>7</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Finkelstein</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <chapter-title>Cholera, <italic>Vibrio cholerae</italic> O1 and O139, and Other Pathogenic Vibrios</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Baron</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <source>Medical Microbiology</source>
            <edition>4th</edition>
            <publisher-name>University of Texas Medical Branch at Galveston</publisher-name>
            <publisher-loc>Galveston (TX)</publisher-loc>
            <year>1996</year>
            <pub-id pub-id-type="pmid">21413330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Merrell</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Qadri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dolganov</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Alam</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Calderwood</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Schoolnik</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Camilli</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Host-induced epidemic spread of the cholera bacterium.</article-title>
            <source>Nature</source>
            <year>2002</year>
            <month>Jun</month>
            <day>06</day>
            <volume>417</volume>
            <issue>6889</issue>
            <fpage>642</fpage>
            <page-range>642-5</page-range>
            <pub-id pub-id-type="pmid">12050664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dutta</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chowdhury</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pazhani</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Guin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dutta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rajendran</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nandy</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Mukhopadhyay</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Mitra</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Takeda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Ramamurthy</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Vibrio cholerae non-O1, non-O139 serogroups and cholera-like diarrhea, Kolkata, India.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>464</fpage>
            <page-range>464-7</page-range>
            <pub-id pub-id-type="pmid">23622872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Somboonwit</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Menezes</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Holt</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Sinnott</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Shapshak</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Current views and challenges on clinical cholera.</article-title>
            <source>Bioinformation</source>
            <year>2017</year>
            <volume>13</volume>
            <issue>12</issue>
            <fpage>405</fpage>
            <page-range>405-409</page-range>
            <pub-id pub-id-type="pmid">29379258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oprea</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Njamkepo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cristea</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zhukova</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Kravetz</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Monakhova</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ciontea</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Cojocaru</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rauzier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Damian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gascuel</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Quilici</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Weill</surname>
                <given-names>FX</given-names>
              </name>
            </person-group>
            <article-title>The seventh pandemic of cholera in Europe revisited by microbial genomics.</article-title>
            <source>Nat Commun</source>
            <year>2020</year>
            <month>Oct</month>
            <day>22</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>5347</fpage>
            <pub-id pub-id-type="pmid">33093464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waldor</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Mekalanos</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Lysogenic conversion by a filamentous phage encoding cholera toxin.</article-title>
            <source>Science</source>
            <year>1996</year>
            <month>Jun</month>
            <day>28</day>
            <volume>272</volume>
            <issue>5270</issue>
            <fpage>1910</fpage>
            <page-range>1910-4</page-range>
            <pub-id pub-id-type="pmid">8658163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siddique</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Cash</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Cholera outbreaks in the classical biotype era.</article-title>
            <source>Curr Top Microbiol Immunol</source>
            <year>2014</year>
            <volume>379</volume>
            <fpage>1</fpage>
            <page-range>1-16</page-range>
            <pub-id pub-id-type="pmid">24368696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raslan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>El Sayegh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chams</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chams</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Leone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hajj Hussein</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Re-Emerging Vaccine-Preventable Diseases in War-Affected Peoples of the Eastern Mediterranean Region-An Update.</article-title>
            <source>Front Public Health</source>
            <year>2017</year>
            <volume>5</volume>
            <fpage>283</fpage>
            <pub-id pub-id-type="pmid">29119098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davies</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Bowman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Luby</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Cholera - management and prevention.</article-title>
            <source>J Infect</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>74 Suppl 1</volume>
            <fpage>S66</fpage>
            <page-range>S66-S73</page-range>
            <pub-id pub-id-type="pmid">28646965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nelson</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Calderwood</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Camilli</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cholera transmission: the host, pathogen and bacteriophage dynamic.</article-title>
            <source>Nat Rev Microbiol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>7</volume>
            <issue>10</issue>
            <fpage>693</fpage>
            <page-range>693-702</page-range>
            <pub-id pub-id-type="pmid">19756008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reidl</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Klose</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>Vibrio cholerae and cholera: out of the water and into the host.</article-title>
            <source>FEMS Microbiol Rev</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>125</fpage>
            <page-range>125-39</page-range>
            <pub-id pub-id-type="pmid">12069878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hartley</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Hyperinfectivity: a critical element in the ability of V. cholerae to cause epidemics?</article-title>
            <source>PLoS Med</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>e7</fpage>
            <pub-id pub-id-type="pmid">16318414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harris</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>LaRocque</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Dorer</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Chowdhury</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Faruque</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Sack</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Qadri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Calderwood</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity.</article-title>
            <source>Infect Immun</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>73</volume>
            <issue>11</issue>
            <fpage>7422</fpage>
            <page-range>7422-7</page-range>
            <pub-id pub-id-type="pmid">16239542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Czerwi&#x00144;ski</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Blood groups - minuses and pluses. Do the blood group antigens protect us from infectious diseases?].</article-title>
            <source>Postepy Hig Med Dosw (Online)</source>
            <year>2015</year>
            <month>Jun</month>
            <day>25</day>
            <volume>69</volume>
            <fpage>703</fpage>
            <page-range>703-22</page-range>
            <pub-id pub-id-type="pmid">26206987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levine</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Clements</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Cisneros</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nalin</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Duration of infection-derived immunity to cholera.</article-title>
            <source>J Infect Dis</source>
            <year>1981</year>
            <month>Jun</month>
            <volume>143</volume>
            <issue>6</issue>
            <fpage>818</fpage>
            <page-range>818-20</page-range>
            <pub-id pub-id-type="pmid">7252264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Keukeleire</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hoste</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Crivits</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hammami</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Piette</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Atypical manifestation of Vibrio cholerae: fear the water!</article-title>
            <source>Acta Clin Belg</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>73</volume>
            <issue>6</issue>
            <fpage>462</fpage>
            <page-range>462-464</page-range>
            <pub-id pub-id-type="pmid">29916306</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knirel</surname>
                <given-names>YA</given-names>
              </name>
              <name>
                <surname>Widmalm</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Senchenkova</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Jansson</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Weintraub</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Structural studies on the short-chain lipopolysaccharide of Vibrio cholerae O139 Bengal.</article-title>
            <source>Eur J Biochem</source>
            <year>1997</year>
            <month>Jul</month>
            <day>01</day>
            <volume>247</volume>
            <issue>1</issue>
            <fpage>402</fpage>
            <page-range>402-10</page-range>
            <pub-id pub-id-type="pmid">9249053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lippi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gotuzzo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Caini</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cholera.</article-title>
            <source>Microbiol Spectr</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>4</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">27726771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harris</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>LaRocque</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Qadri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Calderwood</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Cholera.</article-title>
            <source>Lancet</source>
            <year>2012</year>
            <month>Jun</month>
            <day>30</day>
            <volume>379</volume>
            <issue>9835</issue>
            <fpage>2466</fpage>
            <page-range>2466-2476</page-range>
            <pub-id pub-id-type="pmid">22748592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roy</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>A Case of Cholera Sicca.</article-title>
            <source>Ind Med Gaz</source>
            <year>1934</year>
            <month>Jul</month>
            <volume>69</volume>
            <issue>7</issue>
            <fpage>394</fpage>
            <pub-id pub-id-type="pmid">29009163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rabbani</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>The acidosis of cholera. Contributions of hyperproteinemia, lactic acidemia, and hyperphosphatemia to an increased serum anion gap.</article-title>
            <source>N Engl J Med</source>
            <year>1986</year>
            <month>Dec</month>
            <day>18</day>
            <volume>315</volume>
            <issue>25</issue>
            <fpage>1591</fpage>
            <page-range>1591-5</page-range>
            <pub-id pub-id-type="pmid">3785323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ma</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Thiagarajah</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sonawane</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Folli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Galietta</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Verkman</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.</article-title>
            <source>J Clin Invest</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>110</volume>
            <issue>11</issue>
            <fpage>1651</fpage>
            <page-range>1651-8</page-range>
            <pub-id pub-id-type="pmid">12464670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dube</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moffatt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Davison</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bartels</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Health Outcomes for Children in Haiti Since the 2010 Earthquake: A Systematic Review.</article-title>
            <source>Prehosp Disaster Med</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-88</page-range>
            <pub-id pub-id-type="pmid">29248034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barzilay</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Schaad</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Magloire</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mung</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Boncy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dahourou</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Mintz</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Steenland</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Vertefeuille</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Tappero</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Cholera surveillance during the Haiti epidemic--the first 2 years.</article-title>
            <source>N Engl J Med</source>
            <year>2013</year>
            <month>Feb</month>
            <day>14</day>
            <volume>368</volume>
            <issue>7</issue>
            <fpage>599</fpage>
            <page-range>599-609</page-range>
            <pub-id pub-id-type="pmid">23301694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boncy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rossignol</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dahourou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hast</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Buteau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stanislas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moffett</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bopp</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Balajee</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Performance and utility of a rapid diagnostic test for cholera: notes from Haiti.</article-title>
            <source>Diagn Microbiol Infect Dis</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>76</volume>
            <issue>4</issue>
            <fpage>521</fpage>
            <page-range>521-3</page-range>
            <pub-id pub-id-type="pmid">23886437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hasan</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Huq</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mukhopadhyay</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Loomis</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bernstein</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Colwell</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>Development and testing of monoclonal antibody-based rapid immunodiagnostic test kits for direct detection of Vibrio cholerae O139 synonym Bengal.</article-title>
            <source>J Clin Microbiol</source>
            <year>1995</year>
            <month>Nov</month>
            <volume>33</volume>
            <issue>11</issue>
            <fpage>2935</fpage>
            <page-range>2935-9</page-range>
            <pub-id pub-id-type="pmid">8576349</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ontweka</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>LO</given-names>
              </name>
              <name>
                <surname>Rauzier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Debes</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Tadesse</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Wamala</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Bior</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Lasuba</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>But</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Grandesso</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jamet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cohuet</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ciglenecki</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Serafini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sack</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Quilici</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Azman</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Luquero</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Page</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Cholera Rapid Test with Enrichment Step Has Diagnostic Performance Equivalent to Culture.</article-title>
            <source>PLoS One</source>
            <year>2016</year>
            <volume>11</volume>
            <issue>12</issue>
            <fpage>e0168257</fpage>
            <pub-id pub-id-type="pmid">27992488</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Debes</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Ateudjieu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guenou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ebile</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sonkoua</surname>
                <given-names>IT</given-names>
              </name>
              <name>
                <surname>Njimbia</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Steinwald</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ram</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sack</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Clinical and Environmental Surveillance for Vibrio cholerae in Resource Constrained Areas: Application During a 1-Year Surveillance in the Far North Region of Cameroon.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>537</fpage>
            <page-range>537-543</page-range>
            <pub-id pub-id-type="pmid">26755564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sayeed</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Islam</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hossain</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Akter</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Alam</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Sultana</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Khanam</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Charles</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Kov&#x000e1;&#x0010d;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Andrews</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Calderwood</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Amin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Qadri</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Development of a new dipstick (Cholkit) for rapid detection of Vibrio cholerae O1 in acute watery diarrheal stools.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>e0006286</fpage>
            <pub-id pub-id-type="pmid">29538377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matias</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Julceus</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Abelard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mayo-Smith</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Franke</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Ivers</surname>
                <given-names>LC</given-names>
              </name>
            </person-group>
            <article-title>Laboratory evaluation of immunochromatographic rapid diagnostic tests for cholera in Haiti.</article-title>
            <source>PLoS One</source>
            <year>2017</year>
            <volume>12</volume>
            <issue>11</issue>
            <fpage>e0186710</fpage>
            <pub-id pub-id-type="pmid">29091945</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Banwell</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Worldwide impact of oral rehydration therapy.</article-title>
            <source>Clin Ther</source>
            <year>1990</year>
            <volume>12 Suppl A</volume>
            <fpage>29</fpage>
            <page-range>29-36; discussion 36-7</page-range>
            <pub-id pub-id-type="pmid">2187610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liamis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Filippatos</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Elisaf</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Correction of hypovolemia with crystalloid fluids: Individualizing infusion therapy.</article-title>
            <source>Postgrad Med</source>
            <year>2015</year>
            <month>May</month>
            <volume>127</volume>
            <issue>4</issue>
            <fpage>405</fpage>
            <page-range>405-12</page-range>
            <pub-id pub-id-type="pmid">25812486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahalanabis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Kallen</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Mondal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pierce</surname>
                <given-names>NF</given-names>
              </name>
            </person-group>
            <article-title>Water and electrolyte losses due to cholera in infants and small children: a recovery balance study.</article-title>
            <source>Pediatrics</source>
            <year>1970</year>
            <month>Mar</month>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>374</fpage>
            <page-range>374-85</page-range>
            <pub-id pub-id-type="pmid">5442912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nalin</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Cash</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Islam</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Molla</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Oral maintenance therapy for cholera in adults.</article-title>
            <source>Lancet</source>
            <year>1968</year>
            <month>Aug</month>
            <day>17</day>
            <volume>2</volume>
            <issue>7564</issue>
            <fpage>370</fpage>
            <page-range>370-3</page-range>
            <pub-id pub-id-type="pmid">4173788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murphy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Volmink</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Reduced osmolarity oral rehydration solution for treating cholera.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2004</year>
            <month>Oct</month>
            <day>18</day>
            <issue>4</issue>
            <fpage>CD003754</fpage>
            <pub-id pub-id-type="pmid">15495063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lebenthal</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Khin-Maung-U</surname>
              </name>
              <name>
                <surname>Khin-Myat-Tun</surname>
              </name>
              <name>
                <surname>Tin-Nu-Swe</surname>
              </name>
              <name>
                <surname>Thein-Thein-Myint</surname>
              </name>
              <name>
                <surname>Jirapinyo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Visitsuntorn</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ismail</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bakri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Firmansyah</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>High-calorie, rice-derived, short-chain, glucose polymer-based oral rehydration solution in acute watery diarrhea.</article-title>
            <source>Acta Paediatr</source>
            <year>1995</year>
            <month>Feb</month>
            <volume>84</volume>
            <issue>2</issue>
            <fpage>165</fpage>
            <page-range>165-72</page-range>
            <pub-id pub-id-type="pmid">7538837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pierce</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Fontaine</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Sack</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Amylase-resistant starch plus oral rehydration solution for cholera.</article-title>
            <source>N Engl J Med</source>
            <year>2000</year>
            <month>Jun</month>
            <day>29</day>
            <volume>342</volume>
            <issue>26</issue>
            <fpage>1995</fpage>
            <page-range>1995-6</page-range>
            <pub-id pub-id-type="pmid">10877651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gregorio</surname>
                <given-names>GV</given-names>
              </name>
              <name>
                <surname>Gonzales</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Dans</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>EG</given-names>
              </name>
            </person-group>
            <article-title>Polymer-based oral rehydration solution for treating acute watery diarrhoea.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2016</year>
            <month>Dec</month>
            <day>13</day>
            <volume>12</volume>
            <issue>12</issue>
            <fpage>CD006519</fpage>
            <pub-id pub-id-type="pmid">27959472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhattacharyya</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Hati</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>WHO formula of ORS and home made ORS.</article-title>
            <source>J Indian Med Assoc</source>
            <year>1994</year>
            <month>Feb</month>
            <volume>92</volume>
            <issue>2</issue>
            <fpage>69</fpage>
            <page-range>69-70</page-range>
            <pub-id pub-id-type="pmid">8071565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Butler</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Treatment of severe cholera: a review of strategies to reduce stool output and volumes of rehydration fluid.</article-title>
            <source>Trans R Soc Trop Med Hyg</source>
            <year>2017</year>
            <month>May</month>
            <day>01</day>
            <volume>111</volume>
            <issue>5</issue>
            <fpage>204</fpage>
            <page-range>204-210</page-range>
            <pub-id pub-id-type="pmid">28957470</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wright</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Loo</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Hirayama</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Biology of human sodium glucose transporters.</article-title>
            <source>Physiol Rev</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>91</volume>
            <issue>2</issue>
            <fpage>733</fpage>
            <page-range>733-94</page-range>
            <pub-id pub-id-type="pmid">21527736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <collab>Centers for Disease Control and Prevention (CDC)</collab>
            <article-title>Update on cholera --- Haiti, Dominican Republic, and Florida, 2010.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2010</year>
            <month>Dec</month>
            <day>24</day>
            <volume>59</volume>
            <issue>50</issue>
            <fpage>1637</fpage>
            <page-range>1637-41</page-range>
            <pub-id pub-id-type="pmid">21178947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leibovici-Weissman</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Neuberger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bitterman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sinclair</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Salam</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobial drugs for treating cholera.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2014</year>
            <month>Jun</month>
            <day>19</day>
            <volume>2014</volume>
            <issue>6</issue>
            <fpage>CD008625</fpage>
            <pub-id pub-id-type="pmid">24944120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>GREENOUGH</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>GORDON</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>ROSENBERG</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>DAVIES</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>BENENSON</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>TETRACYCLINE IN THE TREATMENT OF CHOLERA.</article-title>
            <source>Lancet</source>
            <year>1964</year>
            <month>Feb</month>
            <day>15</day>
            <volume>1</volume>
            <issue>7329</issue>
            <fpage>355</fpage>
            <page-range>355-7</page-range>
            <pub-id pub-id-type="pmid">14090856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhandari</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mazumder</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Taneja</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dube</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Mahalanabis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fontaine</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Bhan</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of zinc supplementation plus oral rehydration salts compared with oral rehydration salts alone as a treatment for acute diarrhea in a primary care setting: a cluster randomized trial.</article-title>
            <source>Pediatrics</source>
            <year>2008</year>
            <month>May</month>
            <volume>121</volume>
            <issue>5</issue>
            <fpage>e1279</fpage>
            <page-range>e1279-85</page-range>
            <pub-id pub-id-type="pmid">18450870</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Imdad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mayo-Wilson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Herzer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bhutta</surname>
                <given-names>ZA</given-names>
              </name>
            </person-group>
            <article-title>Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Mar</month>
            <day>11</day>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>CD008524</fpage>
            <pub-id pub-id-type="pmid">28282701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Cummings</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis.</article-title>
            <source>PLoS Med</source>
            <year>2007</year>
            <month>Mar</month>
            <day>27</day>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>e98</fpage>
            <pub-id pub-id-type="pmid">17388664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shane</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Mody</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Crump</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Tarr</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Steiner</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Kotloff</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Langley</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Wanke</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Warren</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Cantey</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pickering</surname>
                <given-names>LK</given-names>
              </name>
            </person-group>
            <article-title>2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.</article-title>
            <source>Clin Infect Dis</source>
            <year>2017</year>
            <month>Nov</month>
            <day>29</day>
            <volume>65</volume>
            <issue>12</issue>
            <fpage>e45</fpage>
            <page-range>e45-e80</page-range>
            <pub-id pub-id-type="pmid">29053792</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hsiao</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Mogasale</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Quentin</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>The health economics of cholera: A systematic review.</article-title>
            <source>Vaccine</source>
            <year>2018</year>
            <month>Jul</month>
            <day>16</day>
            <volume>36</volume>
            <issue>30</issue>
            <fpage>4404</fpage>
            <page-range>4404-4424</page-range>
            <pub-id pub-id-type="pmid">29907482</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hsiao</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Mogasale</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Excler</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Digilio</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings.</article-title>
            <source>Bull World Health Organ</source>
            <year>2017</year>
            <month>Apr</month>
            <day>01</day>
            <volume>95</volume>
            <issue>4</issue>
            <fpage>303</fpage>
            <page-range>303-312</page-range>
            <pub-id pub-id-type="pmid">28479625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwerdtle</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Onekon</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Recoche</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>A Quantitative Systematic Review and Meta-Analysis of the Effectiveness of Oral Cholera Vaccine as a Reactive Measure in Cholera Outbreaks.</article-title>
            <source>Prehosp Disaster Med</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <page-range>2-6</page-range>
            <pub-id pub-id-type="pmid">29317005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desai</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Pezzoli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Alberti</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Perea</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Legros</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era.</article-title>
            <source>Hum Vaccin Immunother</source>
            <year>2017</year>
            <month>Mar</month>
            <day>04</day>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>579</fpage>
            <page-range>579-587</page-range>
            <pub-id pub-id-type="pmid">27813703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poncin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zulu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Voute</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ferreras</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Muleya</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Malama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pezzoli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mufunda</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Robert</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Uzzeni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Luquero</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Chizema</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ciglenecki</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia.</article-title>
            <source>Bull World Health Organ</source>
            <year>2018</year>
            <month>Feb</month>
            <day>01</day>
            <volume>96</volume>
            <issue>2</issue>
            <fpage>86</fpage>
            <page-range>86-93</page-range>
            <pub-id pub-id-type="pmid">29403111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cho</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Macbeth</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Hsiao</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The Interface of <italic>Vibrio cholerae</italic> and the Gut Microbiome.</article-title>
            <source>Gut Microbes</source>
            <year>2021</year>
            <season>Jan-Dec</season>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>1937015</fpage>
            <pub-id pub-id-type="pmid">34180341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <article-title>Responding to the global cholera pandemic.</article-title>
            <source>Bull World Health Organ</source>
            <year>2023</year>
            <month>Apr</month>
            <day>01</day>
            <volume>101</volume>
            <issue>4</issue>
            <fpage>234</fpage>
            <page-range>234-235</page-range>
            <pub-id pub-id-type="pmid">37008267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Kahawita</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Cairncross</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ensink</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>The Impact of Water, Sanitation and Hygiene Interventions to Control Cholera: A Systematic Review.</article-title>
            <source>PLoS One</source>
            <year>2015</year>
            <volume>10</volume>
            <issue>8</issue>
            <fpage>e0135676</fpage>
            <pub-id pub-id-type="pmid">26284367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lund</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Keys</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Leventhal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of cholera risk factors between migrant Haitians and Dominicans in the Dominican Republic.</article-title>
            <source>Rev Panam Salud Publica</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>125</fpage>
            <page-range>125-32</page-range>
            <pub-id pub-id-type="pmid">25988248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bwire</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Munier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ouedraogo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Heyerdahl</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Komakech</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kagirita</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mhlanga</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Njanpop-Lafourcade</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Malimbo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Makumbi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Wandawa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gessner</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Orach</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Mengel</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of cholera outbreaks and socio-economic characteristics of the communities in the fishing villages of Uganda: 2011-2015.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>e0005407</fpage>
            <pub-id pub-id-type="pmid">28288154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31153.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Idoga</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Toycan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zayyad</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Analysis of Factors Contributing to the Spread of Cholera in Developing Countries.</article-title>
            <source>Eurasian J Med</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>121</fpage>
            <page-range>121-127</page-range>
            <pub-id pub-id-type="pmid">31258350</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
